Acadian Asset Management LLC Sells 10,101 Shares of CVS Health Corporation $CVS

Acadian Asset Management LLC lessened its position in shares of CVS Health Corporation (NYSE:CVS) by 8.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 104,802 shares of the pharmacy operator’s stock after selling 10,101 shares during the period. Acadian Asset Management LLC’s holdings in CVS Health were worth $7,225,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Jennison Associates LLC boosted its holdings in shares of CVS Health by 503.8% in the first quarter. Jennison Associates LLC now owns 1,896,341 shares of the pharmacy operator’s stock worth $128,477,000 after acquiring an additional 1,582,257 shares during the period. Cantor Fitzgerald Investment Advisors L.P. lifted its holdings in CVS Health by 1.6% during the 2nd quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 409,735 shares of the pharmacy operator’s stock worth $28,264,000 after purchasing an additional 6,615 shares in the last quarter. Brandywine Global Investment Management LLC boosted its stake in CVS Health by 20.1% in the 1st quarter. Brandywine Global Investment Management LLC now owns 3,421,519 shares of the pharmacy operator’s stock worth $231,808,000 after purchasing an additional 572,533 shares during the period. Skandinaviska Enskilda Banken AB publ grew its holdings in CVS Health by 122.5% during the 1st quarter. Skandinaviska Enskilda Banken AB publ now owns 565,152 shares of the pharmacy operator’s stock valued at $38,289,000 after buying an additional 311,098 shares in the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH increased its position in shares of CVS Health by 1.4% during the first quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 708,479 shares of the pharmacy operator’s stock valued at $47,999,000 after buying an additional 9,634 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Trading Up 0.7%

Shares of CVS opened at $80.44 on Thursday. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $85.15. The firm has a market cap of $102.11 billion, a price-to-earnings ratio of 211.69, a PEG ratio of 0.87 and a beta of 0.60. The firm has a 50 day moving average price of $77.50 and a 200-day moving average price of $69.74. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.62 and a current ratio of 0.83.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company had revenue of $102.87 billion for the quarter, compared to analysts’ expectations of $98.85 billion. During the same quarter last year, the company earned $1.09 EPS. The firm’s revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, equities research analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, November 3rd. Investors of record on Thursday, October 23rd were issued a dividend of $0.665 per share. The ex-dividend date was Thursday, October 23rd. This represents a $2.66 annualized dividend and a yield of 3.3%. CVS Health’s dividend payout ratio is currently 700.00%.

Insider Buying and Selling

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the sale, the director owned 22,156 shares in the company, valued at approximately $1,573,519.12. The trade was a 25.29% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.22% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. Jefferies Financial Group raised their price objective on shares of CVS Health from $92.00 to $98.00 in a research report on Thursday, October 30th. Wells Fargo & Company raised their price target on shares of CVS Health from $84.00 to $103.00 and gave the company an “overweight” rating in a report on Tuesday, October 7th. Truist Financial restated a “buy” rating and set a $95.00 price target (up from $92.00) on shares of CVS Health in a research report on Thursday, October 30th. Sanford C. Bernstein increased their price objective on CVS Health from $72.00 to $77.00 and gave the stock a “market perform” rating in a research report on Friday, September 5th. Finally, Piper Sandler lifted their price objective on CVS Health from $81.00 to $99.00 in a research note on Friday, October 31st. Two analysts have rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $89.45.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.